Sympathetic nervous system activation in postextrasystolic potentiation: Role of catecholamine release in enhancement of ventricular function  by Geschwind, Herbert J. et al.
216 lACC Vol. 4. No.2
August 1984:216--25
Sympathetic Nervous System Activation in Postextrasystolic
Potentiation: Role of Catecholamine Release in Enhancement of
Ventricular Function
HERBERT J. GESCHWIND, MD, FACC, FRAN<;;OIS LHOSTE, MD, ANTONY J. 1. SCRIVEN, MD,
JEAN-FRAN<;;OIS DHAINAUT, MD, CATHERINE SABATIER, DANIEL LAURENT, MD
Creteil, France
The role of catecholamines in postextrasystolic potentia-
tion was assessed in 30 patients during continuous cou-
pled right ventricular pacing. Hemodynamic data were
recorded in 15patients (group 1); in the other 15patients
(group 2), coronary blood flowand metabolic variables,
including catecholamines, were measured. Data were
recorded in the control state and after 10 minutes of
coupled pacing. Both groups had similar control pulse
rates and mean aortic pressures: these variables de-
creased abruptly by 32 beats/min and 12 mm Hg, re-
spectively, (p < 0.001 for each) after the initiation of
coupled pacing. In group 1, all indexes ofleft ventricular
function and contractility increased during coupled pac-
ing (p < 0.001 for each), thus confirming postextrasys-
Postextrasystolic potentiation of myocardial contractility is
known to result in marked enhancement of ventricular func-
tion during the cardiac contraction that follows an extra-
systole. This effect is used in clinical investigation to assess
left ventricular contractile reserve and identify segmental
wall motion abnormalities in ischemic heart disease (1). The
strength of the postextrasystolic contraction has been shown
to be dependent on the prematurity of the extrasystole (2),
but the fundamental mechanism of the potentiation is still
uncertain. Current evidence (3) suggests that the enhanced
myocardial contractility of postextrasystolic potentiation may
be related primarily to increased availability of intracellular
calcium at the contractile sites. The changes in preload and
afterload that occur during the compensatory pause are now
regarded as having a contributory rather than a major role
in the enhancement of the contractile state (4). Since cate-
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tolic potentiation. In group 2, coupled pacing increased
coronary blood flow, myocardial oxygen consumption
and free fatty acid uptake (p < 0.001 for each) but not
lactate extraction. Plasma epinephrine was unchanged,
but norepinephrine levels increased in arterial (421 ±
27 to 576 ± 41 nglIiter) and coronary sinus plasma (611
± 46 to 836 ± 46 nglIiter) (p < 0.001 for both). Indi-
rectly calculated norepinephrine release within the myo-
cardium increased from 25.6 ± 2.8 to 39.7 ± 5.2 ng/min
(SEM) (p < 0.05), suggesting a sympathetic nervous
systemactivation. It is argued that coupledpacing acutely
lowered mean aortic pressure, leading to baroreflex sym-
pathetic activation which may contribute to augmented
cardiac contractility in postextrasystolic potentiation.
cholamines are known to increase calcium influx by alter-
ation of the cellular gating mechanism (5), the present study
was undertaken to determine whether catecholamines have
a role in the enhancement of ventricular function during
postextrasystolic potentiation.
Methods
Patients. Thirty patients were studied during routine
cardiac catheterization (Table 1). Five patients were rou-
tinely taking medication, but this was discontinued at least
24 hours before the study. All catheterizations were per-
formed in the morning with the patient in the fasting state,
supine and premedicated with 10 mg of diazepam
intramuscularly.
Before the experimental study, all patients underwent
diagnostic cardiac catheterization that included biplane left
ventricular cineangiography and, when appropriate, coro-
nary arteriography. Patients with coronary artery stenosis
of greater than 50% or with a left ventricular ejection frac-
tion of less than 0.45 were excluded from the study. For
ethical and technical reasons, it was decided not to obtain
hemodynamic, angiographic and metabolic data simulta-
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Table 1. Patient Data
Age (yr) NYHA
Case &Sex Diagnosis Class EF
Group 1
I 42F MS I 0.70
2 36M CAD II 0.61
3 IBM ASD I 0.66
4 24M ASD I 0.52
5 35M MS I 0.56
6 34M MS II 0.52
7 53F MS I 0.56
8 41F ASD I 0.58
9 45M CAD I 0.64
10 42F MS I 0.70
II 40M AI I 0.73
12 41M AI II 0.45
13 55F AI II 0.54
14 39M AI II 0.51
IS 35M AI II 0.51
Group 2
16 41M CCM I 0.48
17 30M Al II 0.58
18 42F MVP I 0.64
19 42M AI II 0.54
20 48M PDA I 0.55
21 33M AI II 0.49
22 39F MS. MR I 0.49
23 56M AI II 0.55
24 36F MS I 0.65
25 45M CAD II 0.45
26 31M ASD I 0.65
27 39F MS I 0.60
28 50M MS I 0.53
29 47F MS. PHT II 0.54
30 49F MS I 0.69
AI = aortic insufficiency; ASD = atrial septaldefect; CAD = coronary arterydisease;CCM = congestive
cardiomyopathy; EF = ejection fraction; F = female; M = male; MR = mitral regurgitation; MS = mitral
stenosis; MVP = mitral valve prolapse; NYHA = New York Heart Association; PHT = pulmonary arterial
hypertension .
neously in all patients . Thus, although all patients had the
identical protocol , 15 patients (group 1) had only hemo-
dynamic and angiograph ic data recorded, while the re-
maining 15 patients (group 2) had metabolic and hemody-
namic data recorded. This protocol was approved by the
Human Research Committee of University Hospital Henri
Mondor. Informed consent was obtained from all patients.
The ranges of age and sex, diagnosis and functional class
were similar in both groups (Table 1); ejection fraction at
rest was 0.58 ± 0.0 2 in group 1 and 0.56 :t 0.02 in group
2.
Procedure. After completion of the diagnostic study and
the placing of additional catheters, patients from both groups
rested undisturbed for to minutes, after which control data
were recorded. Data were measured again after patients had
undergone sustained coupled right ventricular pacing. The
following data were obtained in the two groups.
Group 1: hemodynamic . These included aortic blood
pressure , heart rate , peak first derivative of left ventricular
pressure (dP/dt) and repeat cineangiographic ejection frac-
tion and mean velocity of circumferential fiber shortening
during coupled pacing .
Group 2: metabolic. These consisted of aortic blood
pressure , heart rate , coronary blood flow and simultaneous
aortic and coronary sinus blood samples for the determi-
nation of levels of norepinephrine , epinephrine , free fatty
acids, lactate, hemoglobin, hematocritand oxygen saturation.
Hemodynamic studies. In group 1, left ventricular pres-
sure was continuously monitored with a 7F high fidelity
microtransducer-tipped catheter equipped with a side hole
for simultaneous aortic pressure recording (Millar Instru-
ments). These data were recorded on a Bell and Howell
recorder and stored in Syscomoramsystem computer (SNIAS,
Bordeaux) for processing and retrieval. The same system
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was used for studies in group 2, but the catheter was po-
sitioned in the ascending aorta. Left ventricular volumes
were computed from biplane cineangiograms using com-
puterized Simpson's rule and ejection phase indexes (ejec-
tion fraction and mean velocity of circumferential fiber
shortening) were derived from these values.
In group 2, coronary blood flow was measured in trip-
licate by a continuous infusion thermodilution technique
using a constant infusion rate of 60 ml of 0.9% sodium
chloride per minute for 30 seconds (6). A 7F two thermistor
catheter (Wilton Webster) was inserted through the femoral
vein and advanced to the coronary sinus. The position of
the sensing thermistor was confirmed fluroscopically by small
injections of contrast medium. In a previous series, we failed
to observe any reflux of contrast medium from the right
ventricle into the coronary sinus during right ventricular
pacing (unpublished observations).
Continuous postextrasystolic potentiation was induced in
both groups by sustained coupled right ventriculat pacing
using a bipolar electrode catheter (USCI) and a 5837 Med-
tronic pacemaker. Single electrical impulses triggered by
the spontaneous QRS complex and adjustably delayed were
applied to the endocardial surface of the right ventricle. The
stimulus was moved progressively earlier in the cycle to
achieve maximal prematurity. The stimulus could be brought
as close to 280 to 310 ms, still yielding a coupled depo-
larization so that the second contraction was minimized.
Thus, a minimal left ventricular pressure response to the
stimulus was achieved while the effect of the potentiated
beat was maximized, as was reflected by the increase in
dP/dt without any significant change in peak systolic left
ventricular pressure. The mechanical effect of the extras-
timulus was observed as either a notch on the descending
limb of the left ventricular pressure curve or a slight systolic
pressure increase so that the peak pressure did not exceed
20 mm Hg. Since the contractile force of the extrasystole
was insufficient to open the aortic valve and cause an in-
crease in pressure in the aorta, the aortic pressure pulses
were caused by the potentiated beats alone. Coupled pacing
with the fixed interval was maintained for 15 minutes to
secure a steady state of potentiation.
Biochemical studies. In group 2, blood samples were
drawn for the estimation of hemoglobin, hematocrit, oxygen
saturation, norepinephrine, epinephrine, free fatty acids and
lactate. Oxygen partial pressures were determined by a po-
larographic method using a BMS 3 Radiometer apparatus.
Oxygen binding capacity was measured using a LEX-02-
CON apparatus (Lexington Instruments). Oxygen content
was calculated from oxygen partial pressures, oxyhemoglo-
bin saturation (MOS 1 Radiometer apparatus) and oxygen
binding capacity. Norepinephrine and epinephrine were as-
sayed in duplicate by a sensitive and specific double isotope
radioenzymatic technique (7). Lactate and free fatty acids
were assayed by conventional methods.
Catecholamine measurements. In our laboratory, av-
erage arterial plasma levels for norepinephrine and epi-
nephrine in the resting state are 500 ± 50 and 40 ± 10
ng/liter, respectively. Estimates of inter- and intra-assay
variation are 4.8 and 2.5%, respectively. Using calculations
based on coronary blood flow data and plasma aortic and
coronary sinus catecholamine concentrations, variables of
myocardial catecholamine turnover were estimated.
Catecholamine influx. This refers to the rate of delivery
of norepinephrine and epinephrine to the myocardium in the
coronary arterial blood and is determined by:
Influx (ng/min) = CBF X (Cat)AO X (l - hematocrit),
where CBF = coronary blood flow and (Cat)Ao = aortic
catecholamine concentrations.
Catecholamine efflux. This refers to the total efflux of
norepinephrine and epinephrine from the myocardium to the
systemic circulation in the coronary venous effluent, and is
calculated as:
Efflux (ng/min) = CBF X (Catks x (1 - hematocrit),
where (Catks = coronary sinus catecholamine concentration.
Norepinephrine overflow. This refers to the net addition
of norepinephrine to the blood flowing through the coronary
circulation, and is determined by:
Norepinephrine overflow (ng/min) = CBF x (CatkS.AO x
(1 - hematocrit).
Myocardial catecholamine uptake. During their passage
through vascular beds, catecholamines are continuously taken
up from the plasma into neuronal and extraneuronal binding
sites. The arteriovenous difference for epinephrine across
all organs except the adrenal glands reflects tissue uptake
alone because only the adrenal glands (outside the brain)
can synthetize epinephrine (8). Thus epinephrine uptake is
given by:
Epinephrine uptake (ng/min) = CBF x (E)A - (E)y x
(1 - hematocrit)
and
(E)A - (E)y
Percent uptake = x 100,(E)A
where (E)A and (E)« = arterial and venous concentration
of epinephrine, respectively. This method cannot be applied
directly to norepinephrine uptake because norepinephrine is
also released into the blood perfusing an organ. However,
since norepinephrine (NE) and epinephrine (E) share the
same uptake mechanism (9) and have been shown to have
similar percent uptakes (10), norepinephrine uptake can be
estimated indirectly according to: norepinephrine uptake
(ng/min) = E% uptake x NE influx.
Myocardial norepinephrine release. This refers to nor-
epinephrine that spills over from the synaptic cleft and dif-
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fuses into the coronary blood. Although not a direct measure
of the rate of neurotransmitter discharge, the spillover of
norepinephrine from the synapse has been shown to correlate
closely with changes in sympathetic nerve activity (11).
Using an adaptation of the method of Levy and Blattberg
(12), the quantity of norepinephrine (NE) appearing in the
coronary venous blood (norepinephrine overflow) repre-
sents: NE influx + NE release - NE uptake. Thus: Myo-
cardial norepinephrine release (ng/min) = NE overflow +
NE uptake - NE influx.
Statistical analysis. Data are given as mean values ±
standard error of the mean. Data obtained under control
conditions and during coupled pacing were compared using
the paired Student's t test; differences were regarded as
significant when probability values were less than O.05.
Results
Heart rate and blood pressure. In both groups, cou-
pled pacing caused a profound decrease in the effective
arterial pulse rate because only the potentiated (and not the
extrasystolic) contractions opened the aortic valves. Thus,
the control heart rate in group 1 was 77.1 ± 1.9 beats/min
and this decreased to 42.8 ± 1.1 beats/min (I' < 0.001);
the decrease in group 2 was similar, from 73.5 ± 2.4 to
42.3 ± 0.8 beats/min (p < 0.001).
This was accompanied by immediate and significant de-
Figure 1. The characteristically abrupt decrease in aortic diastolic
pressure at the onset of coupled pacing. AP = aortic pressure;
ECG = electrocardiogram; M = mean aortic pressure.
creases in mean (as a consequence of the lengthened interval
between beats [Fig. I]) aortic blood pressure from 85.2 ±
3.9 to 73.7 ± 2.9 mm Hg in group 1 and from 91.4 ±
2.6 to 79.4 ± 2.6 mm Hg in group 2 (I' < 0.001 for both)
(Tables 2 and 3). Thus, in both groups the decrease in mean
aortic pressure was similar and due principally to a decrease
in the diastolic component because systolic pressure did not
change during coupled pacing.
Group 1: ventricular function data. In group 1, the
ejection fraction, mean rate of circumferential fiber short-
ening and left ventricular peak dP/dt all increased signifi-
cantly (p < 0.001) during coupled pacing. This response
was observed for all three variables of left ventricular func-
tion in all patients (Table 2).
Group 2: metabolic and catecholamine data. Coronary
blood flow increased in all patients during coupled pacing
from a mean of 142.3 ± 11 to 176.8 ± 15 mllmin (I' <
0.001). This was associated with an increase in myocardial
oxygen consumption (p < 0.001) that was due in part to
the change in coronary flow and in part to a small but
significant (p < 0.01) increase in the arteriovenous oxygen
difference (from 11.5 ± 0.5 to 12.5 ± 0.5 ml/min).
The mean basal aortic and coronary sinus plasma nor-
epinephrine levels were 0.421 and 0.611 ng/ml, respec-
tively, showing a net release of norepinephrine by the heart.
During coupled pacing, these levels increased in all 15 pa-
tients to 0.576 and 0.836 ng/ml, respectively. Although
these increases were relatively small (approximately 35%),
they were highly significant (p < 0.001 for both) due to the
uniformity of the response (Table 3). The mean venoarterial
norepinephrine difference increased slightly, from O. 190ng/
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Table 2. Group 1: Hemodynamic Effects of Coupled Right Ventricular Pacing
Case State HR Mean AoP LV Peak dP/dt EF Vcf
C 85 100 1,700 0.70 1.6
CP 43 70 3,000 0.79 2.1
2 C 88 92 1,800 0.61 1.3
CP 45 82 3,800 0.77 2.0
3 C 76 89 1,500 0.66 1.6
CP 40 71 3,000 0.72 2.1
4 C 83 95 1,500 0.52 1.1
CP 41 92 3,000 0.64 1.5
5 C 76 80 1,400 0.56 1.4
CP 49 73 3,100 0.72 1.8
6 C 70 74 1,800 0.52 1.3
CP 38 61 2,600 0.76 2.1
7 C 67 74 1,700 0.56 1.1
CP 42 57 2,700 0.83 2.5
8 C 75 105 1,900 0.58 1.5
CP 43 98 4,200 0.77 1.8
9 C 80 93 1,700 0.64 1.5
CP 44 79 2,100 0.79 1.9
10 C 94 93 1,700 0.70 1.6
CP 52 83 2,600 0.74 2.1
11 C 72 82 1,400 0.73 1.6
CP 45 73 2,000 0.77 2.0
12 C 71 71 900 0.45 1.0
CP 34 61 1,550 0.71 1.5
13 C 69 70 1,000 0.54 1.1
CP 39 65 1,300 0.60 1.5
14 C 75 81 1,200 0.51 1.4
CP 44 71 1,550 0.66 1.7
15 C 76 79 1,000 0.51 1.0
CP 43 70 1,500 0.72 1.1
Mean control 77.1 85.2 1,480 0.586 1.34
± SEM 1.9 3.9 83 0.02 0.06
Mean coupled 42.8 73.7 2,530 0.733 1.85
pacing ± SEM 1.1* 2.9* 222* 0.02* 0.09*
*p < 0.001. AoP = aortic pressure (mm Hg); C = control; CP = coupled right ventricular pacing; EF
= ejection fraction; HR = heart rate (beats/min); LV Peak dP/dt = peak first derivative of left ventricular
pressure (mm Hg); Vcf = mean velocity of circumferential fiber shortening (circumferences per second).
ml during basal conditions to 0.260 ng/ml during coupled
pacing. However, because individual responses were more
variable (11 subjects with increased and 4 with reduced
venoarterial difference during coupled pacing), this increase
was not significant. For the same reason, although the mean
overflow of norepinephrine from the myocardium increased
by 68% during coupled pacing (from 15.1 ± 2.5 to 25.5
± 4.5 ng/min), this change just failed to reach levels of
significance (p = 0.056) in the two tailed t test (Fig. 2).
The mean basal plasma epinephrine levels in aortic and
coronary sinus blood were 0.083 and 0.054 ng/ml, respec-
tively, showing a net extraction of epinephrine in the coro-
nary vascular bed (p < 0.001). These levels did not change
significantly during coupled pacing and the arteriovenous
epinephrine difference was also unchanged.
The calculated influx and efflux rates increased signifi-
cantly for both epinephrine (p < 0.05) and norepinephrine
(p < 0.001) due to the enhanced coronary blood flow and
the increase in plasma levels of norepinephrine and epi-
nephrine (Fig. 2 and 3). The basal rate of epinephrine uptake
was 2.23 ± 0.41 ng/min and this was unchanged during
coupled pacing at 2.41 ± 0.055 ng/min (Fig. 3). Thus the
percent uptake of epinephrine was reduced from 35 ± 1 to
26 ± 5%, but this was not significant. The calculated rate
lACC Vol. I. No.2
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Table3. Group 2: Metabolic and Catecholamine Effects of Coupled Right Ventricular Pacing
Lactate Free Fatty Acids Norepineph rine Epinephrin e
(mmoli liter) (u mol/Iitcr) (ng/Iiter) (ng/liter)
Ca-e State HR Mean AoP CBF A-CS02 MV02 A CS A CS A CS A CS
16 C 70 103 152 13.0 19.8 1.2~ 2.4 336 543 41 '10
CP 41 100 175 13.2 23.1 1.25 1.65 440 584 153 120
17 C 90 95 190 9.9 18.8 1.7 1.7 473 564 79 72
CP 50 75 273 11.4 31.1 1.5 1.65 941 1,058 122 11 3
18 C 62 83 121 9.5 11.5 0.9 0.85 564 906 71 70'
CP 43 73 152 9.6 14.6 1.4 1.35 610 944 65 52
19 C 90 86 263 13 .2 34.7 504 403 342 366 69 41
CP 43 64 328 14.6 47.9 787 638 515 654 100 70
20 C 61 94 105 lOA 10.9 596 585 479 485 79 62
CP 35 82 112 lOA 11.6 563 526 546 610 70 66
21 C 70 97 124 10.1 12.5 912 843 319 43\ III 49
CP 41 76 226 10.7 24.2 812 619 524 1.184 125 99
22 C 64 99 103 13.1 13 .5 0.9 0.9 343 593 40 21
CP 40 89 148 12.7 18.8 0.85 0.9 441 801 52 51
23 C 65 107 178 l l.8 21 0.9 0.8 1.005 879 534 883 105 77
CP 43 93 2\3 13.5 28.8 0.8 0.9 1,406 1,148 718 876 86 84
24 C 80 84 122 12.1 14.8 0.90 0.85 386 319 296 465 105 67
CP 46 76 148 12.7 18.8 0.90 0.80 596 316 403 699 108 57
25 C 83 83 146 11.8 17 .2 l AO 1.35 253 571 61 46
CP 44 73 169 13 22 2.30 2.0 399 621 65 52
2f C 68 107 101 12 12.1 1.20 1.0 566 554 445 732 169 106
CP 44 93 137 12.5 17.2 0.93 0.80 605 479 655 951 157 79
2: C 75 80 126 6A 8.6 0.90 0.95 409 319 384 436 162 129
CP 40 76 134 9 11.3 1.05 1.50 661 484 744 802 133 78
2~. C 70 95 102 13.7 14.0 0.85 0.90 1,378 1,327 365 528 82 0
CP 41 80 11 0 15 .8 I7A 1.10 1.35 1,151 1,005 380 792 64 30
2'1 C 80 79 161 10.0 16.0 0.75 1.05 663 627 566 790 28 24
CP 42 69 175 12.5 \2.9 0.75 1.20 930 717 643 889 21 18
31) C 75 80 141 14.8 20.9 0.85 0.90 1,313 938 586 870 45 38
CP 42 72 \52 15.3 23.3 1.10 1.10 1,290 1,067 681 971 35 34
Mean con trol 73.5 91.5 142.3 11 .5 16A 1.04 1.\4 779 679 421 611 83 54
± Sl'M 2A 2.6 I I 0.5 1.6 0.10 0.12 11 5 100 27 46 11 9
Mean cr'upled 42.3t 79At 176.8t 12.5' 21.5t 1.16 1.27 880 700 576t 836t 90 66
pacing :t SEM 0.8 2.6 15 0.5 2A 0.11 0.11 96 89 41 46 11 8
' p <: 0.01 versus control; t p < 0.001 versus control. A = aorta; A-CSO z = aortic co ronary sinus oxygen ratio (ml/min); C = control; CBF =
coronary blood flow; CP = coupled right ventricular pacing; CS = coro nary sinus; MVO z = myocardi al oxygen consumption (ml/min).
of norepinephrine release within the myocardium was 25.6
± 2.8 ng/min in the control state; this increased significantly
during coupled pacing to 39 .7 ± 5.2 ng/min (p < 0.05)
(Fig. 2 ).
Lactate concentrations were unchanged during coupled
pacing , but the rate of myocardial free fatty acid uptake
increased threefold (8.34 ± 1.7 to 18.65 ± 3.6 p,mollmin ;
p < 0 .001).
None of the patients experienced subjective discomfort
durin g the study protocol , nor were any changes in their
clinical condition noted .
Discussion
Mechanical effect of postextrasystolic potentiation.
The phenomenon of postextrasystolic potentiation of cardiac
contractility is a fundamental property of both normal and
despressed mammalian myocardium (l ). Although first de-
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Figure 2. Individual and mean (± SEM)changes in norepineph-
rine turnover (influx, effluxand overflow) duringcoupled pacing. Figure 3. Individual and mean (± SEM) changes in epinephrine
turnover (influx, efflux and uptake) during coupled pacing.
scribed by Langendorff in 1885, the mechanism of the ino-
tropic effect is still not fully understood. Studies performed
both in vitro on isometric cardiac muscle and isovolumetric
heart preparations and in vivo in human subjects and intact
animals suggest that three types of mechanism may partic-
ipate. First, in vitro preparations demonstrated that postex-
trasystolic potentiation is associated with a primary aug-
mentation of cardiac contractility which may be related to
increased intracellular calcium availability and which occurs
regardless of changes in preload and afterload (13-16). In
addition, studies in intact animals (13) suggest that the de-
crease in aortic impedance during the compensatory pause
may also enhance contractility, although the magnitude of
this contribution is uncertain. Finally, increased ventricular
filling during the compensatory pause may also contribute
to postextrasystolic potentiation, although a recent study (4)
showed enhanced left ventricular function in the absence of
increased left ventricular end-diastolic volume, and cast doubt
on the importance of the Frank-Starling mechanism in this
context.
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In this study, postextrasystolic potentiation was induced
by sustained coupled ventricular pacing using the shortest
coupling interval to minimize the mechanical effects of the
extrasystoles and maximize the effects of potentiated beats.
Although for ethical reasons it was decided not to subject
our patients to a demanding and complex protocol in order
to obtam simultaneous hemodynamic, angiographic and
metabolic data, this difficulty was partially overcome by
using two similar groups of patients "in parallel," a tech-
nique which albeit less compelling, can still yield useful
data.
Our results in group 1 patients show that sustained cou-
pled pacing markedly enhanced left ventricular function in
all patients. Although it is impossible in vivo to consider
the pumping function of the heart in isolation, the increase
in left ventricular peak dP/dt, an isovolumic index relatively
independent of afterload (18), suggests that cardiac con-
tractility was augmented. The use of each patient as his or
her own control showed that the increase in contractility
was remarkably uniform among all group I patients, re-
gardless of the type of cardiac diseases, and this agrees well
with findings from previous reports (1,4,19-22). Taking
into account the similarity of left ventricular function be-
tween the two groups as judged by ejection fraction and
clinical state, it is reasonable to assume that a similar in-
crease in contractility occurred in the patients in group 2,
since both the technique of coupled pacing and the coupling
interval were identical for group 1. Thus, although it was
not directly assessed, the mechanical effect of sustained
coupled pacing could be expected to be similar to that ob-
tained in group 1 patients.
Role of catecholamines. The inotropic effects of cate-
cholamines are known to be mediated by changes in calcium
influx (5), but the role of endogenous catecholamines in
postextrasystolic potentiation has not been previously in-
vestigated. We have now demonstrated that sustained cou-
pled right ventricular pacing is also accompanied by sig-
nificant increases in both plasma norepinephrine concentration
and rate of release of norepinephrine from the myocardium.
However, in determining the relation between these changes
and the augmentation of contractility induced by coupled
pacing, it is useful to consider the origin of the elevated
circulating norepinephrine.
It is highly unlikely that the increase in plasma norepi-
nephrine resulted solely from increased overflow from the
heart. Tachycardia induced by "regular" pacing is not as-
sociated with elevation of plasma norepinephrine, although
the overflow of norepinephrine from the heart may increase
up to fivefold (23). Furthermore, in our patients, norepi-
nephrine overflow increased from 15.2 ± 2.5 to 25.5 ±
4.5 ng/min with coupled pacing; at the same time, the plasma
norepinephrine level increased by 155 ng/liter. Norepi-
nephrine infusion studies (24,25) suggest that this increase
in plasma norepinephrine would be achieved by a circulatory
input of norepinephrine at a rate of approximately 3 to 5
ng/kg per min. Thus, the 10.3 ng/min increase in norepi-
nephrine overflow in our patients could not itself have ac-
counted for more than 5% of the increase in plasma
norepinephrine.
In contrast, maneuvers such as dynamic (26) and iso-
metric (27) exercise, which are known to stimulate sym-
pathetic nervous activity (28), produce simultaneous in-
creases in peripheraland coronary sinus norepinephrine plasma
levels. The similarity between those findings and the results
reported in this study confirm that coupled right ventricular
pacing was associated with a generalized increase in sym-
pathetic activity which led to the release of norepinephrine
from sympathetic neurons in the heart and peripheral blood
vessels. It is clear, however, that the small increase in cir-
culating norepinephrine from 421 to 576 ng/liter is unlikely
to have increased cardiac contractility. Studies (24,25) of
infused norepinephrine indicate that a plasma concentration
of between 1,000 and 1,800 ng/liter would be the minimal
level required to produce detectable hemodynamic or met-
abolic effects.
Changes in norepinephrine turnover within the myocar-
dium are less easily determined because although the ov-
erflow of norepinephrine from the heart can be derived from
direct measurements, it is uncertain how closely it reflects
cardiac sympathetic activity, being the net result of two
opposing processes, namely, uptake and release. Theoret-
ically more accurate is the use of the arteriovenous epi-
nephrine difference as a marker for norepinephrine uptake
since this allows the indirect assessment of myocardial nor-
epinephrine release. The validity of this method depends
principally on the percent uptake of norepinephrine and
epinephrine being similar. Brown et al. (10) recently showed
in normal subjects and patients with pheochromocytoma that
there was no significant difference between the percent up-
take of norepinephrine and epinephrine over a wide range
of plasma concentrations and in a number of organs in-
cluding the heart.
Our estimates suggest that the mean rate of release of
norepinephrine within the myocardium increased markedly
from 25.6 ± 2.8 ng/min under basal conditions to 39.7 ±
5.2 ng/min during coupled pacing (+ 55%). As this rep-
resents norepinephrine spillover from the synaptic cleft and
reflects changes in neuronal release, it is likely that stim-
ulation of myocardial beta-adrenoceptors was markedly in-
creased and that this led to significant enhancement of car-
diac contractility (29). Pacing-induced cardiac depolarization
itself causes the release of norepinephrine regardless of the
prevailing sympathetic tone (23), but in this study the total
number of depolarizations (sinus plus paced) increased by
only 11%. This is unlikely to have been the sole cause of
the 55% increase in myocardial norepinephrine release. Thus,
the release of norepinephrine in excess of what might be
excepted as a result of pacing alone strengthens the argument
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for enhancement of sympathetic activity within the heart as
a contributory mechanism in postextrasystolic potentiation.
However, since it occurs in isolated hearts, postextra-
systolic potentiation mainly acts by an intropic effect that
is thought to be due to increased intracellular availability
of calcium. The extent of the contributory role of cate-
cholamines in the enhancement of myocardial contractility
was not assessed because the effects of coupled pacing were
not studied during administration of betayadrenoceptor
blocking agents or reserpine.
Catecholamines and myocardial metabolism. The en-
hancement of sympathetic activity within the heart is also
supported by the marked increase in myocardial oxygen
consumption during coupled pacing, which is in agreement
with the findings reported by others (30,31). The increase
in myocardial oxygen consumption occurred despite nearly
a 50% reduction in the number of effective (that is, poten-
tiated) contractions, and the total number of contractions
(potentiated plus extrasystolic) increased by only 11%. A
possible explanation would be that myocardial oxygen con-
sumption increased as a result of the energy demands as-
sociated with the inotropic effect of sympathetic stimulation.
This would be in keeping with the observation of Boerth et
al. (32) that for a given increase in inotropic state, myo-
cardial energy requirements were greater when the increase
was caused by norepinephrine than when it was caused by
increased heart rate. This is largely due to increased free
fatty acid metabolism which is also augmented by cate-
cholamine stimulation, again in excess of changes induced
by pacing alone. Thus, our finding of a large increase in
free fatty acid uptake despite a substantial decrease in ef-
fective heart rate is consistent with an underlying mechanism
of accelerated release of norepinephrine within the
myocardium.
Role of baroreceptors. The observation that regular
cardiac pacing does not itself directly stimulate peripheral
sympathetic activity (23) suggests that the mechanism in-
volved in coupled pacing postextrasystolic potentiation may
be reflex in origin. During the compensatory pause that
precedes a potentiated beat, aortic blood pressure declines
rapidly. Thus, during sustained coupled pacing the mean
aortic pressure decreased abruptly by 12 mm Hg within one
compensatory pause (Fig. 1). Baroreceptors are known to
respond to changes in mean blood pressure and it is likely
that this would lead rapidly by means of vagal disinhibition
or sympathetic activation, or both, to increased release of
norepinephrine. However, the influence of decreased av-
erage aortic pressure may be offset by the increased rate of
pressure increase that occurs during coupled pacing. Animal
studies (33) have shown that reflex changes in heart rate
elicited by common carotid occlusion are mediated princi-
pally by the parasympathetic division of the autonomic ner-
vous system which, in contrast to the relatively slow reaction
time of the sympathetic division (measured in seconds),
allows immediate adjustment of heart rate with time con-
stants as short as 200 ms. It is also clear that changes in
vagal activity may modulate myocardial norepinephrine re-
lease (34). This raises the possibility that beat to beat changes
in cardiac automatic activity may be capable, at least the-
oretically, of influencing postextrasystolic potentiation after
isolated spontaneous extrasystoles.
An autonomic nervous system role in postextrasystolic
potentiation is compatible with intetpretation of myocardial
interval strength relations based on intracellular calcium flux
(35). Studies in animals and human subjects have led to the
concept of an intracellular calcium store whose contents are
discharged to activate contractile proteins on each depolar-
ization. Calcium influx may be accelerated by adrenergic
stimulation, which would enhance filling of calcium stores
during a compensatory pause.
Regarding the relation between cardiac sympathetic ac-
tivity and coronary sinus norepinephrine levels, it has been
observed by others (10) that the overflow of norepinephrine
from an organ does not always correlate well with the den-
sity of its sympathetic innervation. In the dog heart, the
tracer studies of Cousineau et al. (36) suggest that at the
level of the coronary capillary endothelium, there is a barrier
to the inward and outward diffusion of norepinephrine. In
the context of our data, the two important implications of
such a barrier would be: 1) amplification of the effects of
locally released norepinephrine; and 2) attenuation of the
outward diffusion of locally released norepinephrine into
coronary capillary blood. Consequently, estimates of nor-
epinephrine turnover based on coronary sinus norepineph-
rine concentrations will tend to underestimate the true figure.
Furthermore, if changes in the rate of myocardial nor-
epinephrine uptake mask increases in release, it is possible
that cardiac sympathetic activity may vary without neces-
sarily being reflected by equivalent changes in norepineph-
rine overflow. The reduced effectiveness of coupled pacing
in cardiac failure may be due at least in part to decreased
myocardial sensitivity to catecholamines in this condition
(37). In view of the growing interest in myocardial sym-
pathetic function in cardiac failure, further work on tech-
niques for stimulation and quantification of cardiac sym-
pathetic responses in patients is required.
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